These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7163667)

  • 41. [Clinical observations on C3 and CH50 in the serum of patients with systemic lupus erythematosus].
    Jin A
    Zhonghua Yi Xue Za Zhi; 1984 Jan; 64(1):36-8. PubMed ID: 6430492
    [No Abstract]   [Full Text] [Related]  

  • 42. [Current viewpoints on the pathogenesis of lupus erythematosus].
    Sönnichsen N; Haustein UF; Barthelmes H
    Z Arztl Fortbild (Jena); 1971 Jun; 65(12):581-5. PubMed ID: 4939579
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effects of therapies on childhood systemic lupus erythematosus].
    Kurosawa R; Umezawa R; Kobayashi Y; Nakajima S; Miyamae T; Ito S; Imagawa T; Katakura S; Mori M; Aihara Y; Yokota S
    Ryumachi; 2003 Oct; 43(4):632-7. PubMed ID: 14598654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Significance of selected immunological parameters in the diagnosis and follow-up of systemic lupus erythematosus].
    Wollina U; Knopf B; Koch HJ
    Rev Med Chir Soc Med Nat Iasi; 1984; 88(4):697-700. PubMed ID: 6537639
    [No Abstract]   [Full Text] [Related]  

  • 45. Methotrexate therapy in childhood systemic lupus erythematosus.
    Abud-Mendoza C; Sturbaum AK; Vazquez-Compean R; Gonzalez-Amaro R
    J Rheumatol; 1993 Apr; 20(4):731-3. PubMed ID: 8496874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparative evaluation of the effectiveness of corticosteroids and cytostatics in hypertensive variants of systemic nephritis].
    Tareeva IE; Semenkova EN; Filimonova RG; Ianushkevich TN
    Klin Med (Mosk); 1979 Aug; 57(8):30-4. PubMed ID: 502409
    [No Abstract]   [Full Text] [Related]  

  • 47. Some recent immunologic developments in the etiology and treatment of systemic lupus erythematosus.
    Zweiman B; Courter AJ
    Del Med J; 1975 Jun; 47(6):303-10. PubMed ID: 1095433
    [No Abstract]   [Full Text] [Related]  

  • 48. Blepharospasm and autoimmune diseases.
    Jankovic J; Patten BM
    Mov Disord; 1987; 2(3):159-63. PubMed ID: 3509774
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Circulating immune complexes, immunoglobulins and phagocytic activity of neutrophils in the evaluation of the activity and effectiveness of treatment of systemic lupus erythematosus].
    Demin AA; Speranskiĭ AI; Sentiakova TN; Riazantseva TA; Poliachenko EA
    Ter Arkh; 1985; 57(8):52-7. PubMed ID: 4071435
    [No Abstract]   [Full Text] [Related]  

  • 50. [Fluctuation of serum complement activities in systemic lupus erythematosus and its clinical significance].
    Okuda M
    Naika; 1970 Feb; 25(2):353-8. PubMed ID: 5309587
    [No Abstract]   [Full Text] [Related]  

  • 51. [Lupus erythematosus, modern aspects (author's transl)].
    Canavese JC
    Schweiz Rundsch Med Prax; 1977 May; 66(19):565-72. PubMed ID: 69300
    [No Abstract]   [Full Text] [Related]  

  • 52. Prevention of relapses in systemic lupus erythematosus.
    Bootsma H; Spronk P; Derksen R; de Boer G; Wolters-Dicke H; Hermans J; Limburg P; Gmelig-Meyling F; Kater L; Kallenberg C
    Lancet; 1995 Jun; 345(8965):1595-9. PubMed ID: 7783536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Determination of circulating immune complexes in the serum of patients with autoimmune diseases in the active and inactive stage].
    Török K; Gergely P; Petrányi G
    Orv Hetil; 1979 May; 120(18):1071-3. PubMed ID: 440727
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study.
    Mok CC; Lau CS; Wong RW
    Am J Med; 2003 Jul; 115(1):59-62. PubMed ID: 12867236
    [No Abstract]   [Full Text] [Related]  

  • 55. Chemotherapy of lupus nephropathy.
    Donadio JV
    Contrib Nephrol; 1985; 45():200-2. PubMed ID: 3884260
    [No Abstract]   [Full Text] [Related]  

  • 56. Prednisone and azathioprine compared to prednisone plus low-dose azathioprine and cyclophosphamide in the treatment of diffuse lupus nephritis.
    Ginzler E; Diamond H; Guttadauria M; Kaplan D
    Arthritis Rheum; 1976; 19(4):693-9. PubMed ID: 782464
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Study of the DNA-binding capacity of the blood serum in evaluating the activity of systemic lupus erythematosus and scleroderma].
    Glavinskaia TA; Rezaĭkina AV; Komarova VD
    Vestn Dermatol Venerol; 1987; (6):20-2. PubMed ID: 3630357
    [No Abstract]   [Full Text] [Related]  

  • 58. Multiple dermatofibromas in patients with systemic lupus erythematosus on immunosuppressive therapy.
    Newman DM; Walter JB
    N Engl J Med; 1973 Oct; 289(16):842-3. PubMed ID: 4763427
    [No Abstract]   [Full Text] [Related]  

  • 59. [Clinico-immunological characteristics of rheumatoid arthritis and systemic lupus erythematosus].
    Mikunis RI; Kozlova TV
    Ter Arkh; 1983; 55(7):46-9. PubMed ID: 6623383
    [No Abstract]   [Full Text] [Related]  

  • 60. Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis.
    Dinant HJ; Decker JL; Klippel JH; Balow JE; Plotz PH; Steinberg AD
    Ann Intern Med; 1982 Jun; 96(6 Pt 1):728-36. PubMed ID: 7046543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.